PharmiWeb.com - Global Pharma News & Resources
04-May-2021

[2021] Global Tissue and Organ Transplantation Market to Surpass US$ 25.6 Billion by 2027, At a CAGR of 9.1% | Coherent Market Insights

SEATTLE, May 04, 2021, (PHARMIWEB) —

Increasing incidences of chronic disease such as renal diseases, cancer, diabetes, and cardiovascular diseases is expected to propel the market growth over the forecast period. In 2019, the Centers for Disease Control and Prevention (CDC) revealed that around 37 million people or 15% of adult population is suffering from chronic kidney diseases in the U.S.

As per the estimation from World Health Organization (WHO), around 17.9 million people die every year due to cardiovascular diseases globally.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4342

Impact of Coronavirus (Covid-19) Epidemic

The SARS-CoV-2 virus has spread across China and the entire world since December 2019 with recorded cases exponentially increased within a short period of time. Furthermore, the impact and effect of COVID-19 disease has fluctuated largely around the globe. The impact of the pandemic was largely negative for the organ donation and transplantation in nations which have witnesses the high infection rates including the nations such as France, the U.S., and the U.K., all have experienced a decline of 50% in the transplant operations.

The ill patients who were seeking an organ transplant have been impacted badly by the coronavirus disease. As a measure to avoid the transmission of COVID-19 virus, the organ transplantation program was halted temporarily over the lockdown period.

Following the COVID-19 pandemic, the patients suffering from final-stage diseases of liver, lung failure, heart, and kidney are getting panic. However, the patients with kidney failure are likely to experience improvement in their health conditions with continued dialysis but they are also more likely to contract the COVID-19 virus.

Owing to rising incidences of diseases such as renal diseases, cancer, diabetes, Alzheimer’s disease, and cardiovascular diseases, the global tissue and organ transplantation market is expected to experience a CAGR of 9.1% over the forecast period (2020-2027).

Key players contributing in the global tissue and organ transplantation market are Teva Pharmaceuticals, Veloxis Pharmaceutical, CryoLife, Inc., Stryker Corporation, BiolifeSolutions, Inc., Folio Biosciences, Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic PLC, and Novartis AG.

Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/4342

Detailed Segmentation:

By Product Type:

    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs

By Application:

    • Organ Transplantation
    • Tissue Transplantation

By End User:

    • Hospital
    • Transplant Centers
    • Others

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/tissue-and-organ-transplantation-market-3602

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US:

Mr. Shah
Coherent Market Insights,
1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-May-2021